AtriCure (ATRC) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $34.77 -0.52%
Revenue Growth %: +11.6%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
PEBK, DIT, AMC, More
Revenue Growth %: +11.6%
Financial Fact:
Selling, general and administrative expenses: 25.49M
Today's EPS Names:
PEBK, DIT, AMC, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.42), $0.01 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $49.5 million versus the consensus estimate of $59.5 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX sets date for maiden earnings report: Why August 4 is make-or-break
- Washington Trust Bancorp (WASH) Tops Q2 EPS by 6c
- Investar Holding (ISTR) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
